HSCS - HSCSW - Estimated Primary Completion Date : July 2022 Estimated Study Completion Date : July 2022 https://www.clinicaltrials.gov/ct2/show/NCT04804969 "HeartSciences expects to use the net proceeds from the offering primarily to fund FDA clearance for the MyoVista device , including completion of the pivotal clinical validation study, and for working capital and general corporate purposes." https://finance.yahoo.com/news/heart-test-laboratories-inc-announces-135000283.html